Anticuerpos monoclonales | sciencenewsnet.in

Breaking News

No ‘one size fits all’ treatment for Type 1 Diabetes, study finds

Chula Lecturer Wins Creative Excellence Award 2024 for “Decorative Toys for the Elderly”

Improved Spin and Density Correlation Simulations Give Researchers Clearer Insights on Neutron Stars

American Thyroid Association® Recognizes 2024 Van Meter Award Winner

Breakthrough in Hazardous Gas Detection: New Technology Enhances Miniaturization and Accuracy

Shells, teeth and bones of ‘weird and wonderful organisms’ provide historical environmental clues

Forestry Research Indexed in PubMed Central

Technology in Horticulture Successfully Indexed in Web of Science: Emerging Sources Citation Index (ESCI)

Delay and Pay: Tipping Point Costs Quadruple After Waiting

Amazon’s Return-to-Office Strategy: Expert Insights on Remote Work Challenges

27 Nov, 2024

Tratamiento con combinación de anticuerpos monoclonales disminuye hospitalizaciones en pacientes de alto riesgo que contraen COVID-19

September 7, 2021 sarah JonasResearch Results

Los investigadores de Mayo Clinic informan en un estudio observacional que la combinación de casirivimab e imdevimab evita la necesidad de hospitalizar a los pacientes de alto riesgo cuando sufren una infección leve a moderada de la COVID-19.